Cargando…
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
PURPOSE: Previous studies suggested that serum levels of microRNA (miR)-371a-3p (so-called M371 test) have a much higher sensitivity and specificity than the classic markers of testicular germ cell tumors (GCTs) and are applicable toward both seminoma and nonseminoma. We sought to confirm the useful...
Ejemplares similares
-
Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2021) -
Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2022) -
Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2023) -
Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
por: Belge, Gazanfer, et al.
Publicado: (2020) -
MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors
por: Nestler, Tim, et al.
Publicado: (2023)